News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
87,341 Results
Type
Article (1811)
Company Profile (15)
Press Release (85515)
Section
Business (36558)
Career Advice (49)
Deals (5800)
Drug Delivery (3)
Drug Development (10889)
Employer Resources (1)
FDA (1577)
Job Trends (1883)
News (52943)
Policy (2977)
Tag
Academia (134)
Accelerated approval (1)
Allergies (17)
Alliances (3512)
ALS (8)
Alzheimer's disease (145)
Antibody-drug conjugate (ADC) (8)
Approvals (1597)
Artificial intelligence (14)
Autoimmune disease (2)
Bankruptcy (19)
Best Places to Work (1781)
Biosimilars (14)
Biotechnology (14)
Bladder cancer (12)
Brain cancer (1)
Breast cancer (44)
Cancer (307)
Cardiovascular disease (20)
Career advice (42)
Career pathing (4)
CAR-T (17)
Cell therapy (38)
Cervical cancer (2)
Clinical research (9550)
Collaboration (47)
Compensation (39)
COVID-19 (227)
CRISPR (3)
C-suite (10)
Cystic fibrosis (3)
Data (417)
Depression (8)
Diabetes (41)
Diagnostics (986)
Digital health (2)
Diversity, equity & inclusion (2)
Drug discovery (9)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (30102)
Employer resources (2)
Events (12546)
Executive appointments (50)
FDA (1803)
Frontotemporal dementia (1)
Funding (51)
Gene editing (4)
Gene therapy (29)
GLP-1 (86)
Government (217)
Guidances (100)
Healthcare (2415)
IgA nephropathy (6)
Immunology and inflammation (12)
Indications (1)
Infectious disease (248)
Inflammatory bowel disease (21)
Influenza (9)
Intellectual property (12)
Interviews (4)
IPO (4300)
IRA (3)
Job creations (197)
Job search strategy (34)
Kidney cancer (3)
Labor market (5)
Layoffs (24)
Leadership (1)
Legal (531)
Liver cancer (9)
Lung cancer (59)
Lymphoma (30)
Manufacturing (18)
MASH (15)
Medical device (2146)
Medtech (2146)
Mergers & acquisitions (1606)
Metabolic disorders (82)
Multiple sclerosis (10)
NASH (4)
Neurodegenerative disease (9)
Neuroscience (206)
NextGen: Class of 2025 (607)
Non-profit (274)
Now hiring (3)
Obesity (23)
Opinion (7)
Ovarian cancer (9)
Pain (12)
Pancreatic cancer (7)
Parkinson's disease (15)
Patents (27)
Patient recruitment (15)
Peanut (12)
People (3958)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase I (2536)
Phase II (4033)
Phase III (3604)
Pipeline (550)
Policy (5)
Postmarket research (340)
Preclinical (794)
Press Release (10)
Prostate cancer (20)
Radiopharmaceuticals (38)
Rare diseases (30)
Real estate (326)
Regulatory (2395)
Reports (7)
Research institute (115)
Resumes & cover letters (7)
Rett syndrome (1)
RSV (11)
Schizophrenia (10)
Series A (5)
Series B (4)
Sickle cell disease (4)
Spinal muscular atrophy (18)
Startups (137)
Stomach cancer (2)
Supply chain (3)
Tariffs (1)
Vaccines (76)
Venture capitalists (3)
Weight loss (16)
Women's health (1)
Worklife (4)
Date
Last 7 days (270)
Last 30 days (577)
Last 365 days (5402)
2025 (1984)
2024 (5896)
2023 (7083)
2022 (8154)
2021 (9633)
2020 (8675)
2019 (5964)
2018 (4500)
2017 (4578)
2016 (3225)
2015 (4951)
2014 (3087)
2013 (1630)
2012 (1979)
2011 (2452)
2010 (2226)
Location
Africa (59)
Alabama (5)
Arizona (14)
Asia (6726)
Australia (875)
California (1067)
Canada (437)
China (59)
Colorado (50)
Connecticut (44)
Delaware (35)
Europe (10181)
Florida (153)
Georgia (29)
Idaho (2)
Illinois (54)
India (1)
Indiana (94)
Japan (22)
Kansas (27)
Kentucky (14)
Louisiana (4)
Maine (13)
Maryland (157)
Massachusetts (691)
Michigan (30)
Minnesota (59)
Missouri (16)
Montana (11)
Nebraska (2)
Nevada (7)
New Hampshire (10)
New Jersey (335)
New York (397)
North Carolina (148)
Northern California (490)
Ohio (22)
Oklahoma (1)
Oregon (3)
Pennsylvania (294)
Puerto Rico (7)
Rhode Island (1)
South America (119)
South Carolina (1)
Southern California (434)
Tennessee (4)
Texas (139)
United States (4020)
Utah (44)
Virginia (35)
Washington D.C. (5)
Washington State (91)
Wisconsin (4)
87,341 Results for "64".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
mRNA Therapeutics Market Size to Worth USD 42.64 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners
February 28, 2025
·
4 min read
Press Releases
Global Cluster Headache Market size to worth $694.0 million by 2032, at a CAGR of 6.4%, says Coherent Market Insights
April 7, 2025
·
1 min read
Press Releases
Single Cell Genome Sequencing Market Size to Hit Around USD 16.64 Billion by 2033
February 27, 2025
·
1 min read
Deals
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
Protein degradation–focused Neomorph nabs its third Big Pharma deal of around $1.5 billion in less than a year.
January 23, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Zetagen Therapeutics Expands IP Portfolio, Achieving a Milestone of 64 Worldwide Patents in 2024
January 8, 2025
·
3 min read
Press Releases
Gastroesophageal Reflux Disease Market Size to Reach USD 6.4 Billion by 2035, Impelled by Advancements in Personalized Medicine
February 14, 2025
·
10 min read
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
First-in-human PET imaging study of 64Cu-PD-32766 for patients with clear cell renal cell carcinoma were initiated.
June 4, 2024
·
6 min read
Press Releases
Targeted DNA RNA Sequencing Market size to Hit USD 64.43 Bn by 2033
December 17, 2024
·
1 min read
1 of 8,735
Next
